Cargando…
Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521020/ https://www.ncbi.nlm.nih.gov/pubmed/34671566 http://dx.doi.org/10.3389/fonc.2021.773429 |
| _version_ | 1784584809966731264 |
|---|---|
| author | López-Urrutia, Eduardo Padilla-Benavides, Teresita Pérez-Plasencia, Carlos Campos-Parra, Alma D. |
| author_facet | López-Urrutia, Eduardo Padilla-Benavides, Teresita Pérez-Plasencia, Carlos Campos-Parra, Alma D. |
| author_sort | López-Urrutia, Eduardo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8521020 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85210202021-10-19 Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses López-Urrutia, Eduardo Padilla-Benavides, Teresita Pérez-Plasencia, Carlos Campos-Parra, Alma D. Front Oncol Oncology Frontiers Media S.A. 2021-10-04 /pmc/articles/PMC8521020/ /pubmed/34671566 http://dx.doi.org/10.3389/fonc.2021.773429 Text en Copyright © 2021 López-Urrutia, Padilla-Benavides, Pérez-Plasencia and Campos-Parra https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology López-Urrutia, Eduardo Padilla-Benavides, Teresita Pérez-Plasencia, Carlos Campos-Parra, Alma D. Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses |
| title | Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses |
| title_full | Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses |
| title_fullStr | Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses |
| title_full_unstemmed | Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses |
| title_short | Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses |
| title_sort | editorial: repurposed drugs targeting cancer signaling pathways: dissecting new mechanism of action through in vitro and in vivo analyses |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521020/ https://www.ncbi.nlm.nih.gov/pubmed/34671566 http://dx.doi.org/10.3389/fonc.2021.773429 |
| work_keys_str_mv | AT lopezurrutiaeduardo editorialrepurposeddrugstargetingcancersignalingpathwaysdissectingnewmechanismofactionthroughinvitroandinvivoanalyses AT padillabenavidesteresita editorialrepurposeddrugstargetingcancersignalingpathwaysdissectingnewmechanismofactionthroughinvitroandinvivoanalyses AT perezplasenciacarlos editorialrepurposeddrugstargetingcancersignalingpathwaysdissectingnewmechanismofactionthroughinvitroandinvivoanalyses AT camposparraalmad editorialrepurposeddrugstargetingcancersignalingpathwaysdissectingnewmechanismofactionthroughinvitroandinvivoanalyses |